The UK blood and blood forming organs medicine sales are poised for a steady growth from 2024 to 2028, with forecasts indicating an increase from 2.07 to 2.28 billion USD. Compared to the actual sales in 2023, which stood at 2.00 billion USD, the year-on-year growth rate ranges from approximately 2.42% to 2.27%. The compound annual growth rate (CAGR) over this five-year period is estimated to be 2.48%.

Future trends to watch for include:

Increasing demand due to rising prevalence of chronic diseases and aging population.
Innovation in blood-related therapies and advancements in pharmaceutical technology.
Potential impacts of healthcare policies and regulatory changes on pricing and reimbursement.